![](https://cdn.sanity.io/images/0vv8moc6/genetherapy/5432ef5c84675cbe37c7b613206e1c4b948ac7d6-1200x1200.jpg?fit=crop&auto=format)
Roche Drops Pompe Gene Therapy Program
Roche has discontinued development of its investigational gene therapy SPK-3006, which was being evaluated in the phase 1/2 RESOLUTE trial (NCT04093349) in participants with late-onset Pompe disease.1 Roche adopted the program into its pipeline along …